TGA strengthens infliximab warning

Infliximab treatment may increase the risk of skin cancers in people with psoriasis, the TGA says.

Following a review of Australian and international adverse event data, the TGA added to the drug’s product information a precaution that “psoriasis patients should be monitored for non-melanoma cancers, particularly those patients who have had prior prolonged phototherapy treatment”.